➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Harvard Business School
Dow
Medtronic
Johnson and Johnson

Last Updated: May 14, 2021

DrugPatentWatch Database Preview

Actelion Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Actelion

Drugs and US Patents for Actelion

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actelion UPTRAVI selexipag TABLET;ORAL 207947-005 Dec 21, 2015 RX Yes No 10,828,298   Get Started for $10 Y   Get Started for $10
Actelion UPTRAVI selexipag TABLET;ORAL 207947-002 Dec 21, 2015 RX Yes Yes 8,791,122   Get Started for $10 Y Y   Get Started for $10
Actelion UPTRAVI selexipag TABLET;ORAL 207947-007 Dec 21, 2015 RX Yes No 9,173,881   Get Started for $10   Get Started for $10
Actelion UPTRAVI selexipag TABLET;ORAL 207947-001 Dec 21, 2015 RX Yes No 7,205,302   Get Started for $10 Y Y   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Actelion

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actelion TRACLEER bosentan TABLET;ORAL 021290-001 Nov 20, 2001 5,292,740   Get Started for $10
Actelion ZAVESCA miglustat CAPSULE;ORAL 021348-001 Jul 31, 2003 5,472,969   Get Started for $10
Actelion TRACLEER bosentan TABLET;ORAL 021290-002 Nov 20, 2001 5,292,740   Get Started for $10
Actelion ZAVESCA miglustat CAPSULE;ORAL 021348-001 Jul 31, 2003 5,525,616   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ACTELION drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe for Oral Suspension 32 mg ➤ Subscribe 2019-02-08
➤ Subscribe Tablets 10 mg ➤ Subscribe 2017-10-18

Supplementary Protection Certificates for Actelion Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1345920 132014902244514 Italy   Get Started for $10 PRODUCT NAME: MACITENTAN(OPSUMIT); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/13/893/001-002, 20131220
1400518 1690044-1 Sweden   Get Started for $10 PRODUCT NAME: SELEXIPAG OR SALT THEROF; REG. NO/DATE: EU/1/15/1083 20160519
1400518 CR 2016 00048 Denmark   Get Started for $10 PRODUCT NAME: SELEXIPAG ELLER ET SALT DERAF; REG. NO/DATE: EU/1/15/1083 20160519
0526708 C300097 Netherlands   Get Started for $10 PRODUCT NAME: BOSENTAN, DESGEWENST IN DE VORM VAN EEN ZOUT OF EEN HYDRAAT OF IN DE VORM VAN EEN ESTER VAN DE HYDROXYLGROEP VAN DE 2-HYDROXYETHOXY REST MET EEN ZUUR MET DE FORMULE R5-OH, WAARIN R5 EEN C1-7-ALKANOYL, BENZOYL, OF HETEROCYCLYCARBONYL VOORSTELT; NATL. REGISTRATION NO/DATE: U/1/02/220/001 - 005 20020515; FIRST REGISTRATION: CH IKS 58841 01 - 02 20020228
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Mallinckrodt
Colorcon
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.